FDA clears Vesalio’s latest mechanical thrombectomy device
The US Food and Drug Administration (FDA) has cleared Vesalio’s pVasc NET, expanding the company’s existing pVasc technology portfolio for…
13 Aug 2026
Freenome’s lung cancer test receives FDA breakthrough status
Freenome has secured breakthrough device designation from the US Food and Drug Administration (FDA) for its investigational, blood-based SimpleScreen Lung test for adults. The proposed use targets individuals aged 50…
13 Aug 2026
Wandercraft’s self-balancing exoskeleton wins FDA clearance
Wandercraft has secured US Food and Drug Administration (FDA) clearance for its self-balancing standing exoskeleton, supporting upright mobility for wheelchair users with spinal cord injuries. Paris-based Wandercraft highlighted that its…
13 Aug 2026
Enrolment concludes in BD’s PREVENT trial of Phasix Mesh
Becton, Dickinson and Company (BD) has completed patient enrolment in the PREVENT clinical trial, which is evaluating the use of Phasix Mesh for preventing incisional hernias. The randomised trial has…
12 Aug 2026
Bridge to Life raises $110m to advance liver perfusion system’s rollout
Bridge to Life has raised $110m to support the advance of its perfusion system for preserving donor livers ahead of transplantation. The Illinois-based company’s Series C equity financing round was…
12 Aug 2026
Zepto Life Technology wins $8.9m NIH contract for fungal infection panel
Zepto Life Technology has won a contract worth up to $8.9m from the US National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to advance the…
12 Aug 2026
Abbott and Google Health partner for glucose monitoring solutions
Abbott and Google Health have entered a multi-year collaboration aimed at bringing ongoing glucose monitoring and AI-driven health guidance to users of the Google Health app. The partnership will see…